Health Economics

Navigating the complex landscape of market access is no small feat, especially when faced with stiff competition and limited resources. The MTRC (Market Access...

The off-patent medicines industry plays a vital role in Europe, providing approximately 70% of the medicines patients receive across more than 80% of therapy...

ISPOR, The Professional Society for Health Economics and Outcomes Research, has revealed the winners of its 2023 Health Economics and Outcomes Research (HEOR) Scientific...

On August 29, 2023, the Biden-Harris administration announced the first 10 drugs to be negotiated under the Medicare pricing scheme, as per the Inflation...

The Institute for Hospital Remuneration Systems (INeK) in Germany officially launched the application process for the 2024 innovation funding of novel examination and treatment...

The official journal of ISPOR, Value in Health, has released a report introducing a reimbursement strategy for costly Medicare Part B drugs that offer...

The 2022 Transfer of Value (ToV) disclosure figures reveal an increase of 6% from 2021, reaching a total of €26,140,927. Interestingly, this figure also...

The Global Alliance for Genomics and Health (GA4GH) has initiated ten new international genomic data initiatives. This addition brings the total number of GA4GH...

A webinar in the NHS Whispers series is scheduled for Thursday, October 5th, 2024, where Dr. Farzana Hussain, GP Principal at The Project Surgery,...

The Journal of Health Economics published a study investigating the relationship between an individual's cognitive ability and their decision to receive the COVID-19 vaccination....

AI has already made its mark in healthcare with applications in medical imaging, drug discovery, and virtual wards among others. It's often referred to...

The NHS is currently facing a crisis, with an increase in negative stories about its functioning and an alarming drop-off in public satisfaction. In...

Dr. Mark Davies, the Global Chief Health Officer at IBM, and Prof. Phil Richardson, the Chair and Chief Innovation Officer at Mtech Access, examined...

An Academy of Managed Care Pharmacy (AMCP) dossier is a document used by pharmaceutical and medical device manufacturers to provide clinical and economic evidence...

Calum Jones, Senior Consultant – Health Economics at Mtech Access, held a conversation with Dr. George Magrath, CEO at Lexitas, on the current and...